Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 14
Submit an article Journal homepage
192
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor

Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series

Christine M. Yosta Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA;b Texas Children’s Cancer and Hematology Centers, Houston, TX, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3011-0545
ORCID Icon,
Amos S. Gaikwada Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA;b Texas Children’s Cancer and Hematology Centers, Houston, TX, USA
,
D. Williams Parsonsa Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA;b Texas Children’s Cancer and Hematology Centers, Houston, TX, USA
,
Karen R. Rabina Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA;b Texas Children’s Cancer and Hematology Centers, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-4081-8195
ORCID Icon,
Vincent U. Ganta Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA;b Texas Children’s Cancer and Hematology Centers, Houston, TX, USA
,
Kevin E. Fisherb Texas Children’s Cancer and Hematology Centers, Houston, TX, USA;c Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-6179-0937
ORCID Icon,
Andrea N. Marcogliesea Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA;b Texas Children’s Cancer and Hematology Centers, Houston, TX, USA;c Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-1458-9675
ORCID Icon &
Eric S. Schafera Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA;b Texas Children’s Cancer and Hematology Centers, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-7063-512X
ORCID Icon show all
Pages 3515-3518 | Received 19 Jun 2020, Accepted 17 Aug 2020, Published online: 02 Sep 2020

References

  • Rossi JG, Bernasconi AR, Alonso CN, et al. Lineage switch in childhood acute leukemia: an unusual event with poor outcome. Am J Hematol. 2012;87(9):890–897.
  • Stass S, Mirro J, Melvin S, et al. Lineage switch in acute leukemia. Blood. 1984;64(3):701–706.
  • Dorantes-Acosta E, Pelayo R. Lineage switching in acute leukemias: a consequence of stem cell plasticity?. Bone Marrow Res. 2012;2012:406796.
  • Sakaki H, Kanegane H, Nomura K, et al. Early lineage switch in an infant acute lymphoblastic leukemia. Int J Hematol. 2009;90(5):653–655.
  • Harper DP, Aplan PD. Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects. Cancer Res. 2008;68(24):10024–10027.
  • Pieters R, Schrappe M, De Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007;370(9583):240–250.
  • Szczepanski T, Willemse MJ, Kamps WA, et al. Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: proposal for an easy strategy. Med Pediatr Oncol. 2001;36(3):352–358.
  • Gaikwad A, Bonifant CL, Cubbage M, et al. Detection of lymphoid and myeloid lineages in infantile B-cell acute lymphoblastic leukemia with mixed-lineage leukemia rearrangement by use of flow cytometry and cytogenetic analysis. Clin Lymphoma Myeloma Leuk. 2014;14 Suppl:S2–S5.
  • Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937–951.
  • Gardner R, Wu D, Cherian S, et al. Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy. Blood. 2016;127(20):2406–2410.
  • Rayes A, McMasters RL, O'Brien MM. Lineage switch in MLL-rearranged infant leukemia following CD19-directed therapy. Pediatr Blood Cancer. 2016;63(6):1113–1115.
  • Hou YH, Srour EF, Ramsey H, et al. Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. Blood. 2005;105(9):3488–3492.
  • Pui CH, Frankel LS, Carroll AJ, Raimondi SC, et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. Blood. 1991;77(3):440–447.
  • Pui CH, Rubnitz JE, Hancock ML, et al. Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol. 1998;16(12):3768–3773.
  • Pui CH, Pei D, Coustan-Smith E, et al. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study. Lancet Oncol. 2015;16(4):465–474.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.